Bibliography
Found 52 results
Filters: Keyword is Internal and Author is Morgello, Susan [Clear All Filters]
Ethnic/Racial Disparities in Longitudinal Neurocognitive Decline in People With HIV. J Acquir Immune Defic Syndr. 2022 ;90(1):97-105.
HIV disease duration, but not active brain infection, predicts cortical amyloid beta deposition. AIDS. 2021 ;35(9):1403-1412.
. The Longitudinal Effects of Blood Pressure and Hypertension on Neurocognitive Performance in People Living with HIV. J Acquir Immune Defic Syndr. 2021 .
. . Characteristics of Motor Dysfunction in Longstanding Human Immunodeficiency Virus. Clin Infect Dis [Internet]. 2020 ;71(6):1532-1538. Available from: https://pubmed.ncbi.nlm.nih.gov/31587032/
Coronaviruses and the central nervous system. J Neurovirol. 2020 ;26(4):459-473.
. CCR2 on Peripheral Blood CD14CD16 Monocytes Correlates with Neuronal Damage, HIV-Associated Neurocognitive Disorders, and Peripheral HIV DNA: reseeding of CNS reservoirs?. J Neuroimmune Pharmacol. 2019 ;14(1):120-133.
Ethnic/racial differences in longitudinal neurocognitive change among people living with HIV. 2019 .
Frailty in medically complex individuals with chronic HIV. AIDS. 2019 ;33(10):1603-1611.
Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era. J Infect Dis. 2016 ;213(7):1065-73.
Brain large artery inflammation associated with HIV and large artery remodeling. AIDS. 2016 ;30(3):415-23.
. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients. J Neurovirol. 2016 ;22(2):170-8.
Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study. J Neurovirol. 2016 ;22(4):479-87.
The Relative Utility of Three English Language Dominance Measures in Predicting the Neuropsychological Performance of HIV+ Bilingual Latino/a Adults. Clin Neuropsychol. 2016 ;30(2):185-200.
. Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation. J Acquir Immune Defic Syndr. 2015 ;68(3):281-8.
Brain arterial remodeling contribution to nonembolic brain infarcts in patients with HIV. Neurology. 2015 ;85(13):1139-45.
. CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease. J Neurovirol. 2015 ;21(5):559-67.
JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals. J Leukoc Biol [Internet]. 2015 ;97(2):401-12. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25420915
. Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection. Clin Infect Dis. 2015 ;61(9):1476-84.
Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis. 2015 ;60(3):473-80.
Psychological trauma exposure and co-morbid psychopathologies in HIV+Men and Women. Psychiatry Res. 2015 ;230(3):770-6.
. Reading Ability as an Estimator of Premorbid Intelligence: Does It Remain Stable Among Ethnically Diverse HIV+ Adults?. Clin Neuropsychol. 2015 ;29(7):1034-52.
. The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients. AIDS. 2015 ;29(12):1483-91.
Socioeconomic Status and Neuropsychological Functioning: Associations in an Ethnically Diverse HIV+ Cohort. Clin Neuropsychol. 2015 ;29(2):232-54.
.